Dell's modern Alienware gaming laptops are powerful and cool-looking machines, but they have a reputation of being hefty and ...

At CES 2026, Alienware debuts new antiglare 240Hz OLED panels in its 16-inch Aurora and Area-51 laptops, plus new Intel "Arrow Lake" silicon options. I got to check out the screens up close, and ...

Alienware showcased a range of products, from its impressive RTX 50-Series gaming desktop to new entry-level gaming laptops, ...

The new-for-2025 Alienware 16X Aurora gaming laptop is on sale today at a price that's lower than any Black Friday deal. You can pick up a well-specced laptop featuring an Intel Core Ultra 9 CPU and ...

During Black Friday, Dell lowered the price of its venerable 34" Alienware AW3423DWF QD-OLED gaming monitor from $900 to just $499.99 shipped. That was a new historical price low, but today there's a ...

Over 1,200 new annual U.S. cases of osteosarcoma and Ewing sarcoma in patients under 20 (American Cancer Society, SEER estimates). Additional 2,600 primary bone cancer cases in young adults (20–39) ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) ...

Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (HSCS) (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Enhanced wearable builds on Revi’s strong clinical evidence, meaningful symptom relief, and exceptionally high patient satisfaction. SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the first therapy of its kind for the rare disease and making Italy’s Fondazione ...